BNP/CALL/ALCON AG/75/0.1/20.12.24 Stock

Warrant

DE000PC2WSQ6

Market Closed - Boerse Frankfurt Warrants 10:21:26 2024-06-14 am EDT
0.96 EUR -8.57% Intraday chart for BNP/CALL/ALCON AG/75/0.1/20.12.24
Current month+2.13%
1 month+4.35%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-14 0.96 -8.57%
24-06-13 1.05 0.00%
24-06-12 1.05 +8.25%
24-06-11 0.97 -4.90%
24-06-10 1.02 -5.56%

Real-time Boerse Frankfurt Warrants

Last update June 14, 2024 at 10:21 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ALCON INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC2WSQ
ISINDE000PC2WSQ6
Date issued 2024-01-04
Strike 75 CHF
Maturity 2024-12-20 (188 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.14
Lowest since issue 0.24
Spread 0.01
Spread %1.03%

Company Profile

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Sector
-
More about the company

Ratings for Alcon Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Alcon Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
90.26 USD
Average target price
93.45 USD
Spread / Average Target
+3.54%
Consensus